Axxent Electronic Brachytherapy (eBx™)

The Department of Radiation Oncology now offers Axxent Electronic Brachytherapy (eBx™) by Xoft, Inc. This is a new technology for the treatment of some skin cancers (basal and squamous cell carcinomas). The eBx™ technology is a superficial form of electronic radiotherapy applied directly to the cancerous site. It is painless and usually takes only a few minutes and for most cancers and is given in eight separate doses. 

eBx™ provides new options for:

  • Patients with cosmetically sensitive lesions not interested in or unable to have surgery
  • When resection of larger lesions on the lips, eyelids or ears is difficult or impossible for necessary function
  • More desirable cosmetic outcomes

• For more information visit Radiation Oncology.
Xoft Brochure (pdf)